Intro

This chapter explores a crucial clinical trial evaluating U-Petacitinib and L-Subrutinib for systemic lupus erythematosus. The discussion highlights the challenges in lupus trial design and the potential for these treatments to enhance patient outcomes in rheumatology.

Play episode from 00:00

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app